XML 42 R7.htm IDEA: XBRL DOCUMENT v3.24.0.1
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Cash flows from operating activities:      
Net income (loss) $ (19,193) $ 18,742 $ 16,509
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:      
Depreciation and amortization 8,722 8,119 7,078
Amortization of marketable securities premium 18 58 68
Stock-based compensation 3,540 4,006 4,519
Provision for credit losses 272 (177) 87
Loss on sale of equity investment 166    
(Gain) Loss on disposal of equipment 21 (85) (8)
Return of equity method investments (dividends) 4,316 1,608 774
Equity in income of unconsolidated joint ventures (2,050) (5,957) (4,409)
Deferred tax assets 553 104 2,340
Changes in operating assets and liabilities:      
Accounts receivable 9,306 4,535 (9,748)
Inventories 1,073 (31,412) (12,401)
Prepaid expenses and other current assets (652) (3,486) (798)
Other assets 419 (471) (6,283)
Accounts payable (162) (5,519) 3,563
Accrued liabilities (1,897) (2,127) (3,445)
Other long-term liabilities (1,049) 3,297 (1,151)
Net cash provided by (used in) operating activities 3,403 (8,765) (3,305)
Cash flows from investing activities:      
Purchases of property, plant and equipment (10,475) (28,465) (29,645)
Purchases of available-for-sale debt securities   (2,158) (9,645)
Proceeds from sales and maturities of available-for-sale debt securities 9,582 5,400 480
Proceeds from sales of equity securities - 15% of Jia Mei 827    
Investments in non-marketable equity investments (2,538)    
Net cash used in investing activities (2,604) (25,223) (38,810)
Cash flows from financing activities:      
Proceeds from common stock options exercised 10 518 1,670
Proceeds from sale of subsidiary shares to noncontrolling interests     538
Proceeds from short-term bank loans 56,470 53,078 20,543
Proceeds from long-term loan from noncontrolling interest     1,834
Payments on short-term bank loans (49,210) (17,798) (19,066)
Proceeds from capital increase in subsidiary shares from noncontrolling interests 708 2,233  
Proceeds from long-term loan 635    
Formation of new subsidiary with noncontrolling interests     1,283
Proceeds from issuance of Tongmei's common stock to redeemable noncontrolling interests, net of costs     (1,077)
Net cash provided by financing activities 8,613 38,031 5,725
Effect of exchange rate changes on cash and cash equivalents, and restricted cash (646) 542 551
Net increase (decrease) in cash and cash equivalents, and restricted cash 8,766 4,585 (35,839)
Cash, restricted cash and cash equivalents at the beginning of the year 41,348 36,763 72,602
Cash, restricted cash and cash equivalents at the end of the period 50,114 41,348 36,763
Supplemental disclosures:      
Income taxes paid, net of refunds 686 1,692 3,177
Interest expense paid 1,564    
Supplemental disclosure of non-cash flow information:      
Loan proceeds received by notes receivable 1,481    
Notes receivables paid to purchase fixed assets 4,170 6,835  
Non-cash consideration received from sale of DongFang 585    
Conversion of related party borrowings to Additional Paid-in Capital   1,887  
Investment in subsidiary shares from noncontrolling interest 308 937  
Bank loan proceeds paid directly to a third-party vendor, included in accounts payable   474  
Sales of land and building to unconsolidated joint venture   976  
Consideration payable in connection with construction in progress, included in accrued liabilities $ 6,574 $ 4,135 $ 2,974